Mary E Rinella

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Alcohol Consumption

Methicillin Resistant Staphylococcus Aureus

Top Venues

Hepatology (Baltimore, Md.)

Nature medicine

Nature microbiology

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Aleksander Krag, Mary E Rinella
Steatotic liver disease: a new name to reflect the combined role of alcohol and metabolic dysfunction. Nature medicine 30 (4) (2024)
Aleksander Krag, Mary E Rinella
Steatotic liver disease: a new name to reflect the combined role of alcohol and metabolic dysfunction. Nature medicine 30 (4) (2024)
Aleksander Krag, Mary E Rinella
Steatotic liver disease: a new name to reflect the combined role of alcohol and metabolic dysfunction. Nature medicine (2024)
Fasiha Kanwal, Brent A Neuschwander-Tetri, Stephen Caldwell, Mary E Rinella
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) (2023)
Mary E Rinella, Graciela E Castro Narro, Aleksander Krag, Norah A Terrault, Philip Noel Newsome
Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition' †. Hepatology (Baltimore, Md.) 79 (2) (2023)
Mary E Rinella, Graciela E Castro Narro, Aleksander Krag, Norah A Terrault, Philip Noel Newsome
Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition'†. Hepatology (Baltimore, Md.) (2023)
Fasiha Kanwal, Brent A Neuschwander-Tetri, Stephen Caldwell, Mary E Rinella
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) 79 (5) (2023)
Mary E Rinella, Mohammad Shadab Siddiqui, Manal F Abdelmalek, Stephen Caldwell
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) (2023)
Aleksander Krag, Mary E Rinella
Pioneering the path to NASH biomarker approval. Nature medicine (2023)
Mary E Rinella, Graciela E Castro Narro, Aleksander Krag, Norah A Terrault, Philip Noel Newsome
Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition' †. Hepatology (Baltimore, Md.) 79 (2) (2023)
Mary E Rinella, Graciela E Castro Narro, Aleksander Krag, Norah A Terrault, Philip Noel Newsome
Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition' †. Hepatology (Baltimore, Md.) 79 (2) (2023)
Matthew A Odenwald, Huaiying Lin, Christopher Lehmann, Nicholas P Dylla, Cody G Cole, Jake D Mostad, Téa E Pappas, Ramanujam Ramaswamy, Angelica Moran, Alan L Hutchison, Matthew R Stutz, Mark Dela Cruz, Emerald Adler, Jaye Boissiere, Maryam Khalid, Jackelyn Cantoral, Fidel Haro, Rita A Oliveira, Emily Waligurski, Thomas G Cotter, Samuel H Light, Kathleen G Beavis, Anitha Sundararajan, Ashley M Sidebottom, K Gautham Reddy, Sonali Paul, Anjana Pillai, Helen S Te, Mary E Rinella, Michael R Charlton, Eric G Pamer, Andrew I Aronsohn
Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. Nature microbiology (2023)
Fasiha Kanwal, Brent A Neuschwander-Tetri, Stephen Caldwell, Mary E Rinella
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) 79 (5) (2023)
Mary E Rinella, Graciela E Castro Narro, Aleksander Krag, Norah A Terrault, Philip Noel Newsome
Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition' †. Hepatology (Baltimore, Md.) 79 (2) (2023)
Jeffrey Victor Lazarus, Henry E Mark, Massimo G Colombo, Alessandro Rhyl Demaio, John F Dillon, Jacob George, Hannes Hagström, Samantha L Hocking, Nancy Lee, Mark J Nieuwenhuijsen, Mary E Rinella, Manuel Romero, Joan B Soriano, Jörn Markus Schattenberg, Frank Tacke, Emmanuel A Tsochatzis, Luca Vittorio Valenti, Shira Zelber-Sagi, M Ashworth Dirac, Terry T K Huang
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach. Alimentary pharmacology & therapeutics (2021)
Zobair M Younossi, Mary E Rinella, Arun J Sanyal, Stephen A Harrison, Elizabeth M Brunt, Zachary Goodman, David E Cohen, Rohit Loomba
From NAFLD to MAFLD: Implications of a Premature Change in Terminology. Hepatology (Baltimore, Md.) 73 (3) (2021)